Evidence map›Paper›PMID 35003137›Full record

ReviewFrontiers in immunology2021

Global Perspectives on Immunization Against SARS-CoV-2 During Pregnancy and Priorities for Future Research: An International Consensus Paper From the World Association of Infectious Diseases and Immunological Disorders.

Bahaa Abu-Raya, Shabir A Madhi, Saad B Omer, Gayatri Amirthalingam, Michelle L Giles, Katie L Flanagan, Petra Zimmermann, Miguel O'Ryan, Marco A Safadi, Vassiliki Papaevangelou and 5 more

Open access · goldAbstract readReviewConsensus Statement
In one paragraph

Review in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. SARS-CoV-2 Infection in Pregnancy: Clues and Proof of Adverse Outcomes.International journal of environmental research and public health · 2023
    Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 15 institutions in 13 countries.

Bahaa Abu-RayaDepartment of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
Shabir A MadhiSouth African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Saad B OmerDepartment of Internal Medicine (Infectious Diseases), Yale School of Medicine, New Haven, CT, United States.
Gayatri AmirthalingamImmunisation and Countermeasures Division, National Infection Service, Public Health England, London, United Kingdom.
Michelle L GilesDepartment of Obstetrics and Gynaecology, Monash University, Melbourne, VIC, Australia.
Katie L FlanaganSchool of Medicine, Faculty of Health Sciences, University of Tasmania, Launceston, TAS, Australia.
Petra ZimmermannFaculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
Miguel O'RyanMicrobiology and Mycology Program, Institute of Biomedical Sciences and Millennium Institute of Immunology and Immunotherapy, Faculty of Medicine, University of Chile, Santiago de Chile, Chile.
Marco A SafadiDepartment of Pediatrics, Santa Casa de Sao Paulo School of Medical Sciences, Sao Paulo, Brazil.
Vassiliki PapaevangelouNational and Kapodistrian University of Athens, Third Department of Pediatrics, University Hospital Attikon, Athens, Greece.
Kirsten MaertensCentre for the Evaluation of Vaccination, Vaccine & Infectious Diseases Institute, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Nasamon WanlapakornCenter of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Vicens Diaz-BritoDepartment of Infectious Diseases, Parc Sanitari Sant Joan de Déu,, Barcelona, Spain.
Eline TommeleinDepartment of Pharmacy, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium.
Susanna EspositoPediatric Clinic, Pietro Barilla Children's Hospital, Department of Medicine and Surgery, University of Parma, Parma, Italy.
Barilla (Italy) · ITChulalongkorn University · THClifford Craig Foundation · AUFaculdade de Ciências Médicas da Santa Casa de São Paulo · BRMillennium Institute on Immunology and Immunotherapy · CLMonash University · AUNational and Kapodistrian University of Athens · GRParc Sanitari Sant Joan de Déu · ESPublic Health England · GBSouth African Medical Research Council · ZAUniversity of Antwerp · BEUniversity of British Columbia · CAUniversity of Fribourg · CHVrije Universiteit Brussel · BEYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy is associated with a higher risk for severe morbidity and mortality when compared with infection in non-pregnant women of childbearing age. An increasing number of countries recommend immunization against SARS-CoV-2 in pregnant women. Recent studies provide preliminary and supportive evidence on safety, immunogenicity and effectiveness of coronavirus disease 2019 (COVID-19) vaccines in pregnant women; however, important knowledge gaps remain which warrant further studies. This collaborative consensus paper provides a review of the current literature on COVID-19 vaccines in pregnant women, identifies knowledge gaps and outlines priorities for future research to optimize protection against SARS-CoV-2 in the pregnant women and their infants.

Indexed as

2019-nCoV Vaccine mRNA-1273Ad26COVS1Adoptive TransferAntibodies, ViralBNT162 VaccineCOVID-19COVID-19 VaccinesFemaleHumansInfectious Disease Transmission, VerticalMaternal-Fetal ExchangeMilk, HumanPregnancyPregnancy Complications, InfectiousSARS-CoV-2Spike Glycoprotein, Coronavirus2019-nCoV Vaccine mRNA-1273Ad26COVS1Antibodies, ViralBNT162 VaccineCOVID-19 VaccinesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2COVID-19maternal immunizationmaternal vaccination programpregnant womenSARS-CoV-2

Identifiers

PMID35003137
PMCPMC8733958
OpenAlexW4200021170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.